Literature DB >> 16107549

Differential expression of CYP1A, 2B, and 3A genes in the F344 rat following exposure to a polybrominated diphenyl ether mixture or individual components.

J M Sanders1, L T Burka, C S Smith, W Black, R James, M L Cunningham.   

Abstract

Polybrominated diphenyl ethers (PBDEs), used as flame retardants, have been detected in the environment and in mammalian tissues and fluids. Evidence indicates that PBDE mixtures induce CYPs through aryl hydrocarbon receptor (AhR)-dependent and -independent pathways. The present work has investigated the effects of individual components of a commercial PBDE mixture (DE71) on expression of CYP1A1, a biomarker for activation of the AhR (dioxin-like), and CYP2B and CYP3A, biomarkers for activation of the constitutive androstane and pregnanexreceptors (CAR and PXR), respectively, in the rat. Male F344 rats were dosed orally on three consecutive days with either DE71, PBDE components, 2,2',4,4'-tetraBDE (BDE47), 2,2',4,4',5-pentaBDE (BDE99), 2,2',4,4',5,5'-hexaBDE (BDE153), representative polybrominated dibenzofurans (PBDFs) present in DE71, or reference PCBs. Differential expression of target genes was determined in liver 24 h after the last dose. Quantitative PCR analysis indicated up-regulation of CYP1A1 by DE71; however, the response was weak compared to that for dioxin-like PCB126. Individual PBDE components of DE71 up-regulated CYP1A1 only at the highest administered dose (100 micromol/kg/day). Representative PBDFs efficiently up-regulated CYP1A1; therefore, they, along with other PBDFs and polybrominated dibenzodioxins detected in DE71 and individual PBDE components, may be responsible for most, if not all, dioxin-like properties previously observed for PBDEs. Conversely, PBDEs appear capable of up-regulating CYP2B and CYP3A in rats at doses similar to that for non-dioxin-like PCB153. These results indicate that in vivo PBDE-mediated toxicity would be better categorized by AhR-independent mechanisms, rather than the well-characterized AhR-dependent mechanism associated with exposure to dioxin-like chemicals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107549     DOI: 10.1093/toxsci/kfi288

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  30 in total

1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells.

Authors:  Yan Li; Kai Wang; Qing-Yun Zou; Ronald R Magness; Jing Zheng
Journal:  Toxicology       Date:  2015-08-11       Impact factor: 4.221

2.  Disposition of 2,2',4,4',5,5'-hexabromodiphenyl ether (BDE153) and its interaction with other polybrominated diphenyl ethers (PBDEs) in rodents.

Authors:  J M Sanders; E H Lebetkin; L-J Chen; L T Burka
Journal:  Xenobiotica       Date:  2006-09       Impact factor: 1.908

3.  Determination of in vitro relative potency (REP) values for mono-ortho polychlorinated biphenyls after purification with active charcoal.

Authors:  A K Peters; P E Leonards; B Zhao; A Bergman; M S Denison; M Van den Berg
Journal:  Toxicol Lett       Date:  2006-05-03       Impact factor: 4.372

4.  Organic anion transporting polypeptides in the hepatic uptake of PBDE congeners in mice.

Authors:  Erik Pacyniak; Bruno Hagenbuch; Curtis D Klaassen; Lois Lehman-McKeeman; Grace L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-22       Impact factor: 4.219

5.  Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.

Authors:  June K Dunnick; A Brix; H Cunny; M Vallant; K R Shockley
Journal:  Toxicol Pathol       Date:  2012       Impact factor: 1.902

6.  Polybrominated Diphenyl Ethers and Gut Microbiome Modulate Metabolic Syndrome-Related Aqueous Metabolites in Mice.

Authors:  David K Scoville; Cindy Yanfei Li; Dongfang Wang; Joseph L Dempsey; Daniel Raftery; Sridhar Mani; Haiwei Gu; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2019-05-23       Impact factor: 3.922

Review 7.  The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.

Authors:  Martin Van den Berg; Linda S Birnbaum; Michael Denison; Mike De Vito; William Farland; Mark Feeley; Heidelore Fiedler; Helen Hakansson; Annika Hanberg; Laurie Haws; Martin Rose; Stephen Safe; Dieter Schrenk; Chiharu Tohyama; Angelika Tritscher; Jouko Tuomisto; Mats Tysklind; Nigel Walker; Richard E Peterson
Journal:  Toxicol Sci       Date:  2006-07-07       Impact factor: 4.849

8.  Effects of fluoro substitution on 4-bromodiphenyl ether (PBDE 3).

Authors:  J Klösener; D C Swenson; L W Robertson; G Luthe
Journal:  Acta Crystallogr B       Date:  2008-01-17

9.  Receptor interactions by polybrominated diphenyl ethers versus polychlorinated biphenyls: a theoretical Structure-activity assessment.

Authors:  G Luthe; J A Jacobus; L W Robertson
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

10.  Global gene expression analysis in the livers of rat offspring perinatally exposed to low doses of 2,2',4,4'-tetrabromodiphenyl ether.

Authors:  Alexander Suvorov; Larissa Takser
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.